Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 20th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 20th November 2024,
The Insider Transaction was made by Eenhorst, Jasper 
. The transaction toke place on 18th November 2024. The order was executed at the trading place XETRA. . The aggregated volume was 900.415,00 EUR, based on an average price of 150,07 EUR. The nature of the Investment was not specified.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 8th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 8th August 2024,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 2nd August 2024. The order was executed at the trading place XETRA. . The aggregated volume was 214.679,70 EUR, based on an average price of 134,17 EUR. The nature of the Investment was Sell.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 8th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 8th August 2024,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 1st August 2024. The order was executed at the trading place XETRA. . The aggregated volume was 220.340,00 EUR, based on an average price of 137,71 EUR. The nature of the Investment was Sell.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 10th June 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 10th June 2024,
The Insider Transaction was made by Köhler, Elena . The transaction toke place on 7th June 2024. The order was executed at the trading place Xetra. . The aggregated volume was 49.938,00 EUR, based on an average price of 118,90 EUR. The nature of the Investment was Buy.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 8th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 8th August 2024,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 5th August 2024. The order was executed at the trading place XETRA. . The aggregated volume was 104.600,00 EUR, based on an average price of 130,75 EUR. The nature of the Investment was Sell.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 10th June 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 10th June 2024,
The Insider Transaction was made by Köhler, Elena . The transaction toke place on 7th June 2024. The order was executed at the trading place Xetra. . The aggregated volume was 49.938,00 EUR, based on an average price of 118,90 EUR. The nature of the Investment was Buy.
Shop Apotheke Europe N.V.: A reportable insider transaction was published on 3rd April 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 3rd April 2023,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 30th March 2023. The order was executed at the trading place Xetra. . The aggregated volume was 331.160,00 EUR, based on an average price of 78,85 EUR. The nature of the Investment was Sell.
Shop Apotheke Europe N.V.: A reportable insider transaction was published on 26th January 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 26th January 2023,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 24th January 2023. The order was executed at the trading place Xetra. . The aggregated volume was 19.500,00 EUR, based on an average price of 65,00 EUR. The nature of the Investment was Sell.
Shop Apotheke Europe N.V.: A reportable insider transaction was published on 26th January 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 26th January 2023,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 23rd January 2023. The order was executed at the trading place Xetra. . The aggregated volume was 6.510,00 EUR, based on an average price of 65,10 EUR. The nature of the Investment was Sell.
Shop Apotheke Europe N.V.: A reportable insider transaction was published on 26th January 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 26th January 2023,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 24th January 2023. The order was executed at the trading place Frankfurt. . The aggregated volume was 129.360,00 EUR, based on an average price of 64,68 EUR. The nature of the Investment was Sell.
Shop Apotheke Europe N.V.: A reportable insider transaction was published on 26th January 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 26th January 2023,
The Insider Transaction was made by Holler, Theresa Margarete . The transaction toke place on 23rd January 2023. The order was executed at the trading place Frankfurt. . The aggregated volume was 104.773,99 EUR, based on an average price of 65,48 EUR. The nature of the Investment was Sell.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 113 | 5th November 2024 | EQS Group AG | EQS |
| Corporate Research | 0 | - | - | Corporate Research |
| Short Seller (DE) | 48 | 18th November 2024 | Qube Research & Technologies Limited | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.